<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1130-0558</journal-id>
<journal-title><![CDATA[Revista Española de Cirugía Oral y Maxilofacial]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Esp Cirug Oral y Maxilofac]]></abbrev-journal-title>
<issn>1130-0558</issn>
<publisher>
<publisher-name><![CDATA[ Sociedad Española de Cirugía Oral y Maxilofacial y de Cabeza y Cuello]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1130-05582022000100023</article-id>
<article-id pub-id-type="doi">10.20986/recom.2022.1312/2021</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Mucormicosis rino-órbito-cerebral: casuística en un hospital de tercer nivel en méxico, en 3 años]]></article-title>
<article-title xml:lang="en"><![CDATA[Rhino-orbit-cerebral mucormycosis: casuistic in a third level hospital in Mexico, in 3 years]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cámara López]]></surname>
<given-names><![CDATA[Diego]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Reyes Castañeda]]></surname>
<given-names><![CDATA[Erick Geovanny]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cabrera Arévalo]]></surname>
<given-names><![CDATA[Claudia Elizabeth]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Calvillo Rivera]]></surname>
<given-names><![CDATA[Jesús Gerardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alonso Moctezuma]]></surname>
<given-names><![CDATA[Alejandro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Centro Médico Lic. Adolfo López Mateos Servicio de Cirugía Maxilofacial ]]></institution>
<addr-line><![CDATA[Toluca ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Nacional Autónoma de México  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2022</year>
</pub-date>
<volume>44</volume>
<numero>1</numero>
<fpage>23</fpage>
<lpage>29</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1130-05582022000100023&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1130-05582022000100023&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1130-05582022000100023&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  La mucormicosis es una infección producida por hongos aerobios saprofitos oportunistas de distintos géneros, pertenecientes al orden de los mucorales, patógenos que, bajo condiciones de inmunocompromiso como diabetes y SIDA, producen enfermedades. Existen varias formas de presentación clínica: rinocerebral, pulmonar, mucocutánea, gastrointestinal y diseminada. La presentación rinocerebral es frecuentemente fatal, con una morbimortalidad del 85-100 %, a pesar del uso de la anfotericina B, terapia hiperbárica y resección quirúrgica agresiva. Es primordial el diagnóstico temprano y el soporte sistémico del paciente. La disponibilidad limitada de tratamientos contemporáneos constituye una barrera para los pacientes en entornos de países subdesarrollados.  Pacientes y métodos:  El objetivo es realizar una breve revisión de la literatura acerca de la mucormicosis rino-órbito-cerebral, su incidencia y mortalidad en un hospital de tercer nivel de México.  Resultados:  En un periodo de 3 años (julio de 2018-julio de 2021) se trataron tres pacientes con diagnóstico de mucormicosis rino-órbito-cerebral. Los tres casos revisados presentaron diagnóstico de diabetes mellitus tipo 2 con un mal control de la enfermedad. Dos de los tres pacientes atendidos fallecieron durante su episodio de hospitalización a pesar del manejo multidisciplinario que incluyó soporte multiorgánico y tratamiento quirúrgico radical en todos los casos.  Conclusiones:  La mucormicosis sigue presentando una alta mortalidad en los países en desarrollo, a pesar del avance en los tratamientos médicos y quirúrgicos. El factor pronóstico más importante sigue siendo la detección temprana de la enfermedad y el adecuado tratamiento de las enfermedades asociadas.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  Mucormycosis is an infection produced by opportunistic aerobic saprophytic fungi of different genera, belonging to the order of the Mucorales; pathogens that, under immunocompromised conditions such as diabetes and AIDS, produce diseases. There are several forms of clinical presentation: rhinocerebral, pulmonary, mucocutaneous, gastrointestinal and dissemi­nated. The rhinocerebral presentation is frequently fatal, with a morbidity and mortality of 85-100 % despite the use of amphotericin B, hyperbaric therapy, and aggressive surgical resection. Early diagnosis and systemic patient support are essential. The limited availability of contemporary treatments constitutes a barrier for patients in underdeveloped country settings.  Patients and methods:  The objective is to carry out a brief review of the literature about rhino-orbital-cerebral mucormycosis, its incidence and mortality in a tertiary hospital in Mexico.  Results:  In a period of 3 years (July 2018-July 2021), three patients with a diagnosis of rhino-orbital-cerebral mucormycosis were treated. All the cases presented a diagnosis of type 2 diabetes mellitus with poor control of the disease. Two of three patients died during their hospitalization episode despite multidisciplinary management that included multi-organ support and radical surgical treatment in all cases.  Conclusions:  Mucormycosis continues to present a high mortality in developing countries, despite advances in medical and surgical treatments. The most important prognostic factor continues to be the early detection of the disease and the adequate treatment of associated diseases.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Mucormicosis]]></kwd>
<kwd lng="es"><![CDATA[mucorales]]></kwd>
<kwd lng="es"><![CDATA[inmunosupresión]]></kwd>
<kwd lng="es"><![CDATA[diabetes]]></kwd>
<kwd lng="en"><![CDATA[Mucormycosis]]></kwd>
<kwd lng="en"><![CDATA[mucorales]]></kwd>
<kwd lng="en"><![CDATA[immunosuppression]]></kwd>
<kwd lng="en"><![CDATA[diabetes]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tiraboschi]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Bravo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Stecher]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Melero]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Lasala]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mucormicosis: Una micosis emergente. Medicina (B]]></article-title>
<source><![CDATA[Aires)]]></source>
<year>2012</year>
<volume>72</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>23-7</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Plowes Hernández]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Prado Calleros]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Soberón Marmissolle Daguerre]]></surname>
<given-names><![CDATA[GS]]></given-names>
</name>
<name>
<surname><![CDATA[Sadek González]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Manejo de la mucormicosis rino-orbito-cerebral. Estrategias para evitar o limitar afección intracraneal y mejorar la supervivencia]]></article-title>
<source><![CDATA[Acta Otorrinolaringol Esp]]></source>
<year>2015</year>
<volume>66</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>348-52</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berdai]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Labib]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Harandou]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mucormycose rhinocérébrale compliquant une acidocétose diabétique]]></article-title>
<source><![CDATA[Presse Med]]></source>
<year>2016</year>
<volume>45</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>145-6</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quiroz]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Villanueva]]></surname>
<given-names><![CDATA[JDP]]></given-names>
</name>
<name>
<surname><![CDATA[Lozano]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mucormicosis]]></article-title>
<source><![CDATA[Rev Asoc Colomb Dermatol Cir Dematol]]></source>
<year>2017</year>
<volume>25</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>284-93</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jung]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[SW]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
<name>
<surname><![CDATA[Song]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
<name>
<surname><![CDATA[Cho]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rhinocerebral Mucormycosis: consideration of prognostic factors and treatment modality]]></article-title>
<source><![CDATA[Auris Nasus Larynx]]></source>
<year>2009</year>
<volume>36</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>274-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jose]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Roychoudhury]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kholakiya]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Arya]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Roychoudhury]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Current understanding in the pathophysiology of SARS-CoV-2-associated rhino-orbito-cerebral mucormycosis: A comprehensive review]]></article-title>
<source><![CDATA[J Maxillofac Oral Surg]]></source>
<year>2021</year>
<volume>20</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jeong]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Keighley]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Wolfe]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[WL]]></given-names>
</name>
<name>
<surname><![CDATA[Slavin]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Kong]]></surname>
<given-names><![CDATA[DCM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports]]></article-title>
<source><![CDATA[Clin Microbiol Infect]]></source>
<year>2019</year>
<volume>25</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>26-34</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prakash]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Chakrabarti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global epidemiology of mucormycosis]]></article-title>
<source><![CDATA[J Fungi (Basel)]]></source>
<year>2019</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>26</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chakrabarti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Dhaliwal]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of mucormycosis in India]]></article-title>
<source><![CDATA[Curr Fungal Infect Rep]]></source>
<year>2013</year>
<volume>7</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>287-92</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cornely]]></surname>
<given-names><![CDATA[OA]]></given-names>
</name>
<name>
<surname><![CDATA[Alastruey-Izquierdo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Arenz]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[SCA]]></given-names>
</name>
<name>
<surname><![CDATA[Dannaoui]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Hochhegger]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium]]></article-title>
<source><![CDATA[Lancet Infect Dis]]></source>
<year>2019</year>
<volume>19</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>e405-21</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Spalloni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Chávez]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Avilés]]></surname>
<given-names><![CDATA[LCL]]></given-names>
</name>
<name>
<surname><![CDATA[Cofré]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mucormicosis en pediatría]]></article-title>
<source><![CDATA[Rev Chilena Infectol]]></source>
<year>2004</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Petrikkos]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Skiada]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lortholary]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Roilides]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Walsh]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kontoyiannis]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology and clinical manifestations of mucormycosis]]></article-title>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2012</year>
<volume>54</volume>
<numero>Suppl 1</numero>
<issue>Suppl 1</issue>
<page-range>S23-34</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reddy]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Rakesh]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Chauhan]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rhinocerebral mucormycosis among diabetic patients: An emerging trend]]></article-title>
<source><![CDATA[Mycopathologia]]></source>
<year>2015</year>
<volume>180</volume>
<numero>5-6</numero>
<issue>5-6</issue>
<page-range>389-96</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Royer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Puéchal]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mucormycosis in systemic autoimmune diseases]]></article-title>
<source><![CDATA[Joint Bone Spine]]></source>
<year>2014</year>
<volume>81</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>303-7</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Neville]]></surname>
<given-names><![CDATA[BW]]></given-names>
</name>
</person-group>
<source><![CDATA[Oral and maxillofacial pathology - Elsevier eBook on Intel education study]]></source>
<year>2008</year>
<edition>3a</edition>
<publisher-name><![CDATA[Saunders]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pozo Laderas]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Pontes Moreno]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pozo Salido]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Robles Arista]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Linares Sicilia]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mucormicosis diseminadas en pacientes sin inmunodeficiencias: una enfermedad que también existe]]></article-title>
<source><![CDATA[Rev Iberoam Micol]]></source>
<year>2015</year>
<volume>32</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>63-70</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xipell]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Losno]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia-Vidal]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Rovira]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Alejo-Cancho]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Puig de la Bellacasa]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Características clínicas y evolución de los pacientes diagnosticados de mucormicosis en un hospital de tercer nivel (2012-2016)]]></article-title>
<source><![CDATA[Rev Iberoam Micol]]></source>
<year>2018</year>
<volume>35</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>162-6</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bes]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
<name>
<surname><![CDATA[Sberna]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Rosanova]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ventajas y desventajas de los distintos tipos de anfotericina en pediatría: revisión de la bibliografía]]></article-title>
<source><![CDATA[Arch Argent Pediatr]]></source>
<year>2012</year>
<volume>110</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>46-51</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
